BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7075304)

  • 1. The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon.
    Wise RA; Wigley F; Newball HH; Stevens MB
    Chest; 1982 Jun; 81(6):695-8. PubMed ID: 7075304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the cold pressor test on diffusing capacity. Comparison of normal subjects and those with Raynaud's disease and progressive systemic sclerosis.
    Miller MJ
    Chest; 1983 Sep; 84(3):264-6. PubMed ID: 6884100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon.
    Gastaud M; Dolisi C; Bermon S; Gaudin P; Defauw G; Ardisson JL
    Clin Exp Rheumatol; 1995; 13(5):617-21. PubMed ID: 8575140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon of the lung.
    Fahey PJ; Utell MJ; Condemi JJ; Green R; Hyde RW
    Am J Med; 1984 Feb; 76(2):263-9. PubMed ID: 6695950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concept of Raynaud's phenomenon of the lung revisited.
    Lampert E; Charloux A; Lonsdorfer J; Frans A
    Am J Med; 1996 Nov; 101(5):468-71. PubMed ID: 8948269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis.
    Shuck JW; Oetgen WJ; Tesar JT
    Am J Med; 1985 Feb; 78(2):221-7. PubMed ID: 3970048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of pulmonary capillary blood volume following cold exposure in patients with Raynaud's phenomenon.
    Barr WG; Fahey PJ
    Chest; 1988 Dec; 94(6):1195-9. PubMed ID: 3191759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic response of the digital artery to heat and cold in normal subjects, in systemic scleroderma and in Raynaud's disease].
    Vayssairat M; Mathieu JF; Housset E
    J Mal Vasc; 1984; 9(1):7-10. PubMed ID: 6707534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis.
    Peters-Golden M; Wise RA; Schneider P; Hochberg M; Stevens MB; Wigley F
    Medicine (Baltimore); 1984 Jul; 63(4):221-31. PubMed ID: 6738343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sympathetic blockade and cooling in Raynaud's phenomenon.
    Engelhart M
    Clin Physiol; 1990 Mar; 10(2):131-6. PubMed ID: 2318024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raynaud's phenomenon.
    Wigley FM; Flavahan NA
    Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.
    Pancera P; Sansone S; Presciuttini B; Montagna L; CerĂ¹ S; Lunardi C; Lechi A
    Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible myocardial perfusion defects during cold challenge in scleroderma.
    Long A; Duffy G; Bresnihan B
    Br J Rheumatol; 1986 May; 25(2):158-61. PubMed ID: 3708232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.